drugset / Trial / NCT01376089
Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study is to evaluate and compare overall patient comfort profile between the Iso-osmolar contrast media (IOCM), iodixanol 320 mg I/mL, and a Low-osmolar contrast media (LOCM), iopamidol 370 mg I/mL in patients undergoing Contrast-Enhanced Computed Tomographic (CECT) imaging of the abdomen/pelvis.
Timeline
- Start
- 2011-05
- Primary completion
- 2011-10
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iodixanol | Diagnostic / imaging agent | 320 mg/ml | Intravenous |
| Comparator | Iopamidol | Diagnostic / imaging agent | 370 mg/ml | Intravenous |
Indications
No indication recorded.